NEW REQUIRED MATE ACT TRAINING FOR NURSE PRACTITIONERS

Meet Your DEA Substance Abuse Training Requirement

Get the education you need in your favorite format with courses designed for Nurse Practitioners to meet the Drug Enforcement Administration (DEA)’s new requirement under the Medication Access and Training Expansion (MATE) Act

Starting June 27, 2023, DEA-registered practitioners must complete 8 hours of one-time training on the treatment and management of patients with opioid or other substance use disorders

For Nurse Practitioners

Controlled Substance Prescribing – For DEA Registration Renewal

8 hours

Satisfies mandatory DEA MATE Act requirement in:
Opioids or other substance use disorders
Created by Advanced Practice Nurses specifically for DEA-registered Advanced Practice Nurses
Earn 8 hours of CE pharmacology credit
AANP Accredited Provider

On-Demand Course

8 hours | Self-paced

$149

Get Access Now

In-Person

8 hours | 8am – 5:30 pm EST

Regular $299

Early Bird $249

View Details

Livestream

8 hours | 8am – 5:30 pm EST

Regular $300

Early Bird $199

View Details

DEA-registration renewal course for physicians, dentists, and pharmacists available at Elite Learning.

Controlled Substance Prescribing meets the 8-hour federal requirement to renew DEA registration as of 6/21/23 as mandated by Section 1262 of the Consolidated Appropriations Act, 2023.

Course Description

Presenter: Dr. Sally Miller, PhD, AGACNP, AGPCNP, FNP-BC, PMHNP-BC, FAANP

This 8-hour program meets the requirements of the Consolidated Appropriations Act, 2023, which requires that effective June 27, 2023 all prescribers of controlled substances must have a minimum of 8 hours of continuing education in the assessment and management of opioid or other substance use disorder in order to apply for or renew DEA registration. The program includes principles of pain management, opioid prescribing, opioid risk assessment, legislative issues, and management of opioid-use disorder with medically assisted therapy. Additionally, the program presents non-opioid controlled substance considerations, including psychostimulants, benzodiazepines, appetite suppressants, and sedative hypnotics. Indications, selection, and both assessment and management of use disorders is presented. Successful completion of this program complies with eligibility requirements for initial and renewal DEA registration, and meets most state-mandated requirements for opioid prescribing.

Meet Your CE Requirements with NP CE Passport Membership

Includes your DEA-required training!

Satisfy your DEA-required training

Prescribing Controlled Substances Safely – A DEA Requirement 8-hour course is included

Extensive CE Library

Choose from a library of 150+ on demand courses created by practicing NP experts

Membership community

Enjoy weekly new podcast releases and join your peers to discuss hot topics with NP experts in members only forums

Live learning at your fingertips

Attend livestream and in-person CE classes at no extra cost

NP CE Passport Membership

+ 8-hour DEA-required training

$1,599/year

Get Access Now

Why Learn with Fitzgerald Health Education Associates?

Learn from the Experts

Fitzgerald has been preparing & educating NPs with evidence-based education for 32 years

In-Depth Clinical CE

Expand your clinical skill set & maintain certification

Extensive Pharmacology CE

Increase prescribing skills, maintain certification & stay current

Satisfy mandatory DEA requirements for opioid and other substance use disorders.

Course Description

Nurse Practitioners (NPs), Physician Assistants (PAs), Pharmacists, and Dentists care for patients with disorders in many healthcare settings. Individuals may seek care for an acute illness or worsening of a chronic condition. Often, pain is the leading reason for seeking medical care. Appropriate prescribing practices are critical for all medications, but controlled substances require special attention. The Drug Enforcement Agency (DEA), the Food and Drug Administration (FDA), and the U.S. Department of Health and Human Services (HHS) all have a role in controlled medication schedules. Prescribers must understand federal and state requirements for all controlled substances. This course will provide a general review of federal and state-controlled substance regulations and the prescribing practices for controlled substances. Additionally, substance use disorders are complex phenomena affecting many lives. This course also reviews common substance use disorders, including alcohol, anxiolytics, stimulants, hallucinogens, and tobacco/vaping. However, the focus is on clinical safety considerations when prescribing non-cancer-related opioid medications for acute/chronic pain in adults.

Learning Objectives:
Completion of this course will better enable the course participant to:

Differentiate among substance use disorders and associated concepts, including diversion.
Examine the roles of the DEA, FDA, and HHS in scheduling-controlled substances and enforcing controlled substance laws and regulations.
Controlled substance act
Differentiate the DEA Controlled Substance Schedules and prescribing regulations
DEA Controlled Substance Schedules
Schedules of a controlled substance (I, II, III, IV, V)
Examine medical marijuana legislation
Describe essential considerations when prescribing controlled substances, including regulatory exceptions and clinical concerns.
Nurse practitioners prescribing controlled substances: requirements
Integrative Therapies
Controlled substance prescribing practices
Prescription drug monitoring programs (PDMPs)
Electronic prescribing of controlled substances (EPCS)
Facsimile and oral prescriptions for Schedule II controlled substances
Schedules III-IV controlled substance prescribing considerations
FDA warning for codeine- and hydrocodone-containing cough and cold products
Special considerations for nurse practitioners prescribing controlled substances